UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Compare Roth and Traditional retirement index funds to understand tax treatment and expected growth. This intro highlights how each option fits different retirement goals.
25,919 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Investors watching ecarx (ecx) 2026 earnings want clarity on how software, hardware, and services come together in th...
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
The stock move is sharp, but so is the story behind choice hotels stock down. An investor dumped more than $100 milli...
Quantum Computing Inc. (QUBT) is due to report Q4 2025 results after the market closes, with traders eyeing a narrow ...
Analysts project XRP could climb to multi-dollar levels by 2030, but the path hinges on regulatory outcomes and Rippl...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
Costco reports stronger quarterly results as its $250 billion expansion strategy accelerates, supported by a robust m...
March 2026 brings tighter rules and sharper competition among binary options platforms. This report identifies the be...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...